Skip to main content

Aberdeen Group plc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1716774 EDINBURGH, X0

Position in REGN

as of Mar 31, 2026 · filed Apr 29, 2026
Position Value
$93,755,226
-$31,085,483 QoQ
Shares Held
121,344
-25.0% QoQ
Ownership
0.116%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Aberdeen Group plc holds $1,803,580,461 across 84 Biotechnology names. REGN ranks #2 (5.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
121,344 $93,755,226

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $93,755,226 121,344
2025-12-31 $124,840,709 161,738
2025-09-30 $85,185,590 151,503
2025-06-30 $106,968,750 203,750
2025-03-31 $155,511,292 245,197
2024-12-31 $134,239,299 188,451
2024-09-30 $196,278,070 186,711
2024-06-30 $187,311,412 178,217
2024-03-31 $211,987,458 220,249
2023-12-31 $193,135,969 219,900
2023-09-30 $27,721,406 33,685
2023-06-30 $24,528,079 34,136
2023-03-31 $27,818,457 33,856
2022-12-31 $24,059,525 33,347
2022-09-30 $23,913,431 34,714
2022-06-30 $19,092,906 32,299
2022-03-31 $19,883,317 28,469
2021-12-31 $22,644,410 35,857
2021-09-30 $22,884,275 37,814
2021-06-30 $28,879,308 51,705
2021-03-31 $35,036,961 74,052
2020-12-31 $17,344,131 35,901
2020-09-30 $18,682,096 33,374
2020-06-30 $23,618,248 37,871
2020-03-31 $15,998,332 32,764